BioCentury
ARTICLE | Clinical News

MA09-hRPE cells: Phase I/II ongoing

July 29, 2013 7:00 AM UTC

Advanced Cell Technology said an independent DSMB recommended continuation of enrollment in the third cohort in an open-label, dose-escalation, U.S. Phase I/II trial evaluating sub-retinal transplanta...